To see the other types of publications on this topic, follow the link: Biochemical markers.

Journal articles on the topic 'Biochemical markers'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Biochemical markers.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ahmed, Mohamed H. "Biochemical Markers." American Journal of Clinical Pathology 127, no. 1 (2007): 20–22. http://dx.doi.org/10.1309/jxwum661t8vt1etx.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rothstein, Jeffrey. "Biochemical markers: Pro." Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (2002): S81. http://dx.doi.org/10.1080/146608202320374381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mitsumoto, Hiroshi. "Biochemical markers: Con." Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (2002): S83. http://dx.doi.org/10.1080/146608202320374390.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Strong, Michael J. "Biochemical markers: Summary." Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (2002): S85—S90. http://dx.doi.org/10.1080/146608202320374408.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sandberg, Dr K. "3. Biochemical markers." Animal Genetics 20, no. 1 (2009): 56–83. http://dx.doi.org/10.1111/j.1365-2052.1989.tb01910.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Seishima, Mitsuru, Makiko Suzuki, and Satoshi Maeda. "Atherosclerosis and biochemical markers." SEIBUTSU BUTSURI KAGAKU 48, no. 4 (2004): 143–46. http://dx.doi.org/10.2198/sbk.48.143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Selroos, Olof B. N. "Biochemical Markers in Sarcoidosis." CRC Critical Reviews in Clinical Laboratory Sciences 24, no. 3 (1986): 185–216. http://dx.doi.org/10.3109/10408368609110273.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Đerić, Mirjana, Sunčica Kojić-Damjanov, Velibor Čabarkapa, and Nevena Eremić. "Biochemical Markers of Atherosclerosis." Journal of Medical Biochemistry 27, no. 2 (2008): 148–53. http://dx.doi.org/10.2478/v10011-008-0008-1.

Full text
Abstract:
Biochemical Markers of AtherosclerosisThis paper is a brief review of some lipid parameters and serum markers of inflammation in a view of their predictive relevance for the atherosclerotic disease. A discourse on the importance of measuring different lipids and lipoproteins, concentration of LDL particles and apolipoprotein levels is still underway. Also, the recommendations for apolipoprotein (a), phenotypization and other lipid markers have not yet been established. In recent years the recommendations imply simultaneous measuring of multiple markers and calculating the lipid index values su
APA, Harvard, Vancouver, ISO, and other styles
9

Kanis, John. "Biochemical markers in osteoporosis." Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997): 6–11. http://dx.doi.org/10.3109/00365519709168303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ratcliffe, Anthony, and Markus J. Seibel. "Biochemical markers of osteoarthritis." Current Opinion in Rheumatology 2, no. 5 (1990): 770–76. http://dx.doi.org/10.1097/00002281-199002050-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Kanis, John A. "Biochemical markers in osteoporosis." Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (1997): 6–11. http://dx.doi.org/10.1080/00365519709168303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Jung, Rex E., Ronald A. Yeo, Stephen J. Chiulli, et al. "Biochemical markers of cognition." NeuroReport 10, no. 16 (1999): 3327–31. http://dx.doi.org/10.1097/00001756-199911080-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Ikizler, T. Alp. "Biochemical markers: Clinical aspects." Journal of Renal Nutrition 7, no. 2 (1997): 61–64. http://dx.doi.org/10.1016/s1051-2276(97)90039-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Paselk, R. "Biochemical Markers for Cancer." Biochemical Education 13, no. 1 (1985): 43. http://dx.doi.org/10.1016/0307-4412(85)90154-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Stadtman, E. R. "Biochemical markers of aging." Experimental Gerontology 23, no. 4-5 (1988): 327–47. http://dx.doi.org/10.1016/0531-5565(88)90036-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Samoilova, I. G., M. V. Matveeva, and D. E. Galyukova. "Biochemical markers of autism." Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 124, no. 1 (2024): 55. http://dx.doi.org/10.17116/jnevro202412401155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Duffy, M. J. "Biochemical markers as prognostic indices in breast cancer." Clinical Chemistry 36, no. 2 (1990): 188–91. http://dx.doi.org/10.1093/clinchem/36.2.188.

Full text
Abstract:
Abstract Traditional prognostic markers in breast cancer include histological variables such as tumor size, grade, and axillary node status. In recent years some new potential prognostic markers of a biochemical nature have been described: estradiol receptors, progesterone receptors, epidermal growth factor receptors, erbB-2 proto-oncogene, and certain proteolytic enzymes. None of these new markers excels axillary node status as a prognostic marker. Biochemical markers can, however, be evaluated with use of minimal surgery and may help distinguish the minority of aggressive axillary-node-negat
APA, Harvard, Vancouver, ISO, and other styles
18

Watts, Nelson B. "Clinical Utility of Biochemical Markers of Bone Remodeling." Clinical Chemistry 45, no. 8 (1999): 1359–68. http://dx.doi.org/10.1093/clinchem/45.8.1359.

Full text
Abstract:
Abstract Remodeling is essential for bone health. It begins with resorption of old bone by osteoclasts, followed by the formation of new bone by osteoblasts. Remodeling is coupled (formation is linked to resorption). After middle age or perhaps beginning earlier, bone loss occurs because resorption exceeds formation. This imbalance is accentuated by estrogen deficiency as well as by many diseases and conditions. Biochemical markers that reflect remodeling and can be measured in blood or urine include resorption markers (e.g., collagen cross-links) and formation markers (e.g., alkaline phosphat
APA, Harvard, Vancouver, ISO, and other styles
19

Cheung, K. L., S. E. Pinder, C. Paish, et al. "The Role of Blood Tumor Marker Measurement (Using a Biochemical Index Score and C-Erbb2) in Directing Chemotherapy in Metastatic Breast Cancer." International Journal of Biological Markers 15, no. 3 (2000): 203–9. http://dx.doi.org/10.1177/172460080001500310.

Full text
Abstract:
The role of blood tumor markers in monitoring response in advanced breast cancer is established in endocrine therapy and standard chemotherapy. This study examines marker levels in patients receiving new chemotherapy regimens. Thirty patients were recruited into two multicenter trials in which docetaxel-based regimens were used in 15 patients. The other 15 received doxorubicin-based regimens. Biochemical response calculated from a score using CA15.3, CEA and ESR was compared with UICC response. Marker changes at 2, 4 and 5 months correlated with UICC response at 3, 41/2 and 6 months, respectiv
APA, Harvard, Vancouver, ISO, and other styles
20

Adeli, Khosrow, Victoria Higgins, Michelle Nieuwesteeg, et al. "Biochemical Marker Reference Values across Pediatric, Adult, and Geriatric Ages: Establishment of Robust Pediatric and Adult Reference Intervals on the Basis of the Canadian Health Measures Survey." Clinical Chemistry 61, no. 8 (2015): 1049–62. http://dx.doi.org/10.1373/clinchem.2015.240515.

Full text
Abstract:
Abstract BACKGROUND Biological covariates such as age and sex can markedly influence biochemical marker reference values, but no comprehensive study has examined such changes across pediatric, adult, and geriatric ages. The Canadian Health Measures Survey (CHMS) collected comprehensive nationwide health information and blood samples from children and adults in the household population and, in collaboration with the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER), examined biological changes in biochemical markers from pediatric to geriatric age, establishing a compreh
APA, Harvard, Vancouver, ISO, and other styles
21

Khatoon, Arifa, Sumeet Verma, Gayatri Wadiye, and Anuprita Zore. "Molecular markers and their potentials." International Journal of Bioassays 5, no. 01 (2016): 4706. http://dx.doi.org/10.21746/ijbio.2016.01.003.

Full text
Abstract:
The use of molecular markers, revealing polymorphism at the DNA level, has been playing an increasing part in plant molecular biotechnology and their genetic studies. There are three different types of markers viz. morphological, biochemical and DNA based molecular markers. These DNA based markers are differentiating in two types 1. Non PCR based (RFLP) and 2. PCR based markers (RAPD, AFLP, SSR, SNP etc.). Amongst others, the microsatellite DNA marker is one of the most widely used marker due to its easy use by simple PCR, followed by a denaturing gel electrophoresis. SNP (Single Nucleotide Po
APA, Harvard, Vancouver, ISO, and other styles
22

Franco, Leonardo, and Mario Alejandro Ortíz Salazar. "Biochemical markers of bone metabolism." Revista Estomatología 18, no. 1 (2017): 30–34. http://dx.doi.org/10.25100/re.v18i1.5707.

Full text
Abstract:
The quantity and quality of bone tissue renewal are dependent on the generation of new bone (deposition) mediated by osteoblasts and the loss (resorption) mediated by osteoclasts. For each of these processes there are important markers that can be measured in serum or urine.
 Resorption markers are products of metabolic degradation of bone matrix in particu-lar of the type I collagen (hydroxyproline, pyridinoline and deoxypyridinoline). In addition, the resorptive activity can also be evaluated through the tartrate resistant acid phosphatase (TRAP) and calcium-creatinine ratio in urine. B
APA, Harvard, Vancouver, ISO, and other styles
23

Rosen, Clifford J., and Alan Tenenhouse. "Biochemical markers of bone turnover." Postgraduate Medicine 104, no. 4 (1998): 101–14. http://dx.doi.org/10.3810/pgm.1998.10.447.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Accomando, Salvatore. "Biochemical markers in Celiac disease." Frontiers in Bioscience S2, no. 1 (2010): 313–17. http://dx.doi.org/10.2741/s66.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Bapayeva, G. B. "Biochemical markers of premature birth." Journal of obstetrics and women's diseases 54, no. 3 (2005): 38–41. http://dx.doi.org/10.17816/jowd83449.

Full text
Abstract:
Summary: In this article the results of the research of diagnostic importance of myoglobin determination in peripheral blood and amniotic fluid, fetal fibronectin examination in cervicovaginal composition contents of a pregnant woman are represented in prediction of premature birth.
APA, Harvard, Vancouver, ISO, and other styles
26

Koshul’ko, P. A., M. S. Kovalenko, Yu V. Abalenihina, A. I. Mirov, O. E. Golofast, and E. D. Rokunov. "Biochemical markers of missed pregnancy." Problemy reproduktsii 27, no. 6 (2021): 138. http://dx.doi.org/10.17116/repro202127061138.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Lyubimova, N. V., and N. E. Kushlinskiy. "Biochemical markers of bone metastasis." Advances in molecular oncology 2, no. 1 (2015): 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.061-075.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Lyubimova, N. V., and N. E. Kushlinskiy. "Biochemical markers of bone metastasis." Advances in molecular oncology 2, no. 1 (2015): 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.61-75.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Kovářů, H., F. Kovářů, A. Fišerová, P. Zelníčková, and E. Matalová. "Biochemical Markers of Lymphocyte Maturation." Acta Veterinaria Brno 71, no. 4 (2002): 503–8. http://dx.doi.org/10.2754/avb200271040503.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Delmas, Pierre D. "Biochemical markers of bone turnover." Acta Orthopaedica Scandinavica 66, sup266 (1995): 176–82. http://dx.doi.org/10.3109/17453679509157687.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau, and H. Broll. "Biochemical markers in menopausal women." Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997): 64–72. http://dx.doi.org/10.3109/00365519709168309.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Apple, Fred. "Biochemical markers of thrombolytic success." Scandinavian Journal of Clinical and Laboratory Investigation 59 (1999): 60–66. http://dx.doi.org/10.3109/00365519909168328.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Kemp, M., J. Donovan, H. Higham, and J. Hooper. "Biochemical markers of myocardial injury." British Journal of Anaesthesia 93, no. 1 (2004): 63–73. http://dx.doi.org/10.1093/bja/aeh148.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Kerrigan, Richard W., and Ian K. Ross. "Extracellular Laccases: Biochemical Markers forAgaricusSystematics." Mycologia 80, no. 5 (1988): 689–95. http://dx.doi.org/10.1080/00275514.1988.12025602.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Lyubimova, N. V., T. K. Churikova, M. G. Toms, and N. E. Kushlinskiy. "BIOCHEMICAL MARKERS OF NEUROENDOCRINAL TUMORS." Tambov University Reports. Series: Natural and Technical Sciences 21, no. 2 (2016): 494–510. http://dx.doi.org/10.20310/1810-0198-2016-21-2-494-510.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Krstic, Danijela, Nenad Tomic, Branimir Radosavljevic, et al. "Biochemical Markers of Renal Function." Current Medicinal Chemistry 23, no. 19 (2016): 2018–40. http://dx.doi.org/10.2174/0929867323666160115130241.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Demers, Laurence M., Luis Costa, and Allan Lipton. "Biochemical Markers and Skeletal Metastases." Clinical Orthopaedics and Related Research 415 (October 2003): S138—S147. http://dx.doi.org/10.1097/01.blo0000092979.12414.54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Thompson, R. P. H. "Biochemical markers of liver disease." Current Opinion in Gastroenterology 1, no. 3 (1985): 377–89. http://dx.doi.org/10.1097/00001574-198505000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Matull, W. R. "Biochemical markers of acute pancreatitis." Journal of Clinical Pathology 59, no. 4 (2006): 340–44. http://dx.doi.org/10.1136/jcp.2002.002923.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Engler, H., B. Thürlimann, and F. Riesen. "Biochemical Markers of Bone Remodelling." Oncology Research and Treatment 19, no. 2 (1996): 126–31. http://dx.doi.org/10.1159/000218778.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau, and H. Bröll. "Biochemical markers in menopausal women." Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (1997): 64–72. http://dx.doi.org/10.1080/00365519709168309.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Apple, Fred S. "Biochemical markers of thrombolytic success." Scandinavian Journal of Clinical and Laboratory Investigation 59, sup230 (1999): 60–66. http://dx.doi.org/10.1080/00365519909168328.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Gao, F., and D. N. F. Harris. "Biochemical markers of cerebral damage." European Journal of Anaesthesiology 14, no. 2 (1997): 113–17. http://dx.doi.org/10.1097/00003643-199703000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

De Jongh, R., C. De Deyne, G. Kenis, G. Vundelinckx, L. Merckx, and R. Heylen. "Biochemical markers of brain ischaemia." European Journal of Anaesthesiology 15, Supplement 17 (1998): 14–15. http://dx.doi.org/10.1097/00003643-199801001-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Crofton, P. M., H. F. Stirling, E. Schönau, et al. "Biochemical Markers of Bone Turnover." Hormone Research 45, no. 1 (1996): 55–58. http://dx.doi.org/10.1159/000184832.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Rambotti, Pietro. "Biochemical markers in lymphoproliferative diseases." Critical Reviews in Oncology/Hematology 2, no. 4 (1985): 297–321. http://dx.doi.org/10.1016/s1040-8428(85)80006-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Shepherd, J. "Biochemical risk markers of CHD." Atherosclerosis 144 (May 1999): 144. http://dx.doi.org/10.1016/s0021-9150(99)80558-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Seibel, Markus J. "Biochemical markers of bone remodeling." Endocrinology and Metabolism Clinics of North America 32, no. 1 (2003): 83–113. http://dx.doi.org/10.1016/s0889-8529(02)00077-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Garnero, Patrick, and Pierre D. Delmas. "BIOCHEMICAL MARKERS OF BONE TURNOVER." Endocrinology and Metabolism Clinics of North America 27, no. 2 (1998): 303–23. http://dx.doi.org/10.1016/s0889-8529(05)70007-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Gavaghan, Mary. "Biochemical Markers in Myocardial Injury." AORN Journal 70, no. 5 (1999): 839–54. http://dx.doi.org/10.1016/s0001-2092(06)61303-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!